[ Price : $8.95]
FDA posts a six-item Form FDA-483 that led to a 12/19 Warning Letter to Mylan Laboratories citing its Pradesh, India manufacturing...[ Price : $8.95]
FDA warns Albuquerque, NM-based Sombra Cosmetics about CGMP violations in the manufacturing of finished drugs.[ Price : $8.95]
FDA approves Mesoblasts Ryoncil to treat some graft-versus-host disease pediatric patients.[ Price : $8.95]
FDA publishes a draft guidance on defining, identifying, and reporting protocol deviations in clinical investigations.[ Price : $8.95]
FDA says a Boston Scientific recall updating instructions for two cryoablation balloon catheters is Class 1.[ Price : $8.95]
FDA warns Akorn Formulations in Hyderabad, Telangana, India, about CGMP violations in its production of over-the-counter drugs for...[ Price : $8.95]
FDA issues a complete response letter for Zealands glepaglutide intended to treat short bowel syndrome.[ Price : $8.95]
FDA warns a Viatris Mylan drug manufacturing facility in Pradesh, India, about CGMP violations involving quality and data issues.